Market News AIOpen the app

Guggenheim cut its price target for Twist Bioscience from $212 to $150.

OpinionRead the original at marketscreener.com
Bad for TWST

Guggenheim lowered its estimate for TWST shares from $212 per share to $150 per share. This signals a less favorable view of the shares, though the report includes no new company results.

TWST · Twist Bioscience Corporation

AI read · Bad for TWST

The AI's read

That points to a weaker view of what TWST shares may be worth. The report gives no new sales, profit, or product details, so the concern comes from the analyst’s changed view, not a reported change in Twist’s business.

Get alerts for TWST

Follow Twist Bioscience Corporation (TWST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TWST
Free on the App Store and Google Play, or on the web.